Halozyme Therapeutics, Inc.

US BANCORP \DE\ HALO

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/30/2026

Shares

9,440

Value ($000)

635

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/30/2026	635	0.0%	9,440	12/31/2025
2025 Q3	11/12/2025	758	0.0%	10,330	9/30/2025
2025 Q2	7/24/2025	905	0.0%	17,397	6/30/2025
2025 Q1	5/8/2025	1,502	0.0%	23,535	3/31/2025
2024 Q4	2/5/2025	1,311	0.0%	27,426	12/31/2024
2024 Q3	10/28/2024	1,989	0.0%	34,740	9/30/2024
2024 Q2	8/7/2024	864	0.0%	16,501	6/30/2024
2024 Q1	5/8/2024	566	0.0%	13,912	3/31/2024
2023 Q4	2/9/2024	312	0.0%	8,454	12/31/2023
2023 Q3	11/3/2023	331	0.0%	8,662	9/30/2023
2023 Q2	8/10/2023	306	0.0%	8,487	6/30/2023
2023 Q1	5/9/2023	331	0.0%	8,673	3/31/2023
2022 Q4	2/13/2023	570	0.0%	10,023	12/31/2022
2022 Q3	10/27/2022	447	0.0%	11,305	9/30/2022
2022 Q2	8/1/2022	487	0.0%	11,069	6/30/2022
2022 Q1	5/11/2022	506	0.0%	12,663	3/31/2022
2021 Q4	2/11/2022	354	0.0%	8,804	12/31/2021
2021 Q3	11/10/2021	444	0.0%	10,908	9/30/2021
2021 Q2	8/5/2021	553	0.0%	12,189	6/30/2021
2021 Q1	4/28/2021	540	0.0%	12,950	3/31/2021
2020 Q4	2/4/2021	434	0.0%	10,175	12/31/2020
2020 Q3	11/10/2020	222	0.0%	8,448	9/30/2020
2020 Q2	8/7/2020	226	0.0%	8,448	6/30/2020
2020 Q1	5/13/2020	136	0.0%	7,555	3/31/2020
2019 Q4	2/4/2020	90	0.0%	5,088	12/31/2019